methionine sulfoximine has been researched along with Cystadenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, J; Imaizumi, E; Ishii, K; Kikuchi, Y; Kita, T; Kudoh, K; Nagata, I; Tode, T | 1 |
| Andrews, PA; Howell, SB; Murphy, MP; Schiefer, MA | 1 |
2 other study(ies) available for methionine sulfoximine and Cystadenocarcinoma
| Article | Year |
|---|---|
Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.
Topics: Buthionine Sulfoximine; Cell Division; Cisplatin; Cystadenocarcinoma; Drug Resistance; Female; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion.
Topics: Buthionine Sulfoximine; Cisplatin; Cystadenocarcinoma; Drug Synergism; Female; Glutathione; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured | 1988 |